Instituto de Investigación Sanitaria de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Correction to: Biosafety evaluation of etoposide lipid nanomedicines in C. elegans (Drug Delivery and Translational Research, (2024), 14, 8, (2158-2169), 10.1007/s13346-023-01466-w)

    Drug Delivery and Translational Research

  2. Rna-loaded nanoparticles for the treatment of hematological cancers

    Advanced Drug Delivery Reviews, Vol. 214

2023

  1. Lipid nanoparticles for siRNA delivery in cancer treatment

    Journal of Controlled Release, Vol. 361, pp. 130-146

2022

  1. In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 175, pp. 1-6

  2. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system

    Journal of Controlled Release, Vol. 348, pp. 553-571

2021

  1. Oral lipid nanomedicines: Current status and future perspectives in cancer treatment

    Advanced Drug Delivery Reviews, Vol. 173, pp. 238-251

  2. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608